Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Assess the Analgesic Efficacy and Safety of ASP8062 in Subjects With Fibromyalgia

ClinicalTrials.gov ID: NCT03092726

Public ClinicalTrials.gov record NCT03092726. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 10:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Randomized, Double-Blind Placebo-controlled, Parallel-group Study to Assess the Analgesic Efficacy and Safety of ASP8062 in Subjects With Fibromyalgia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study was to assess analgesic efficacy of ASP8062 relative to placebo as well as the safety and tolerability. This study also assessed the treatment differences in physical function as well the improvements in overall subject status (e.g., fibromyalgia symptoms, global functioning) of ASP8062 relative to placebo.

Study identification

NCT ID
NCT03092726
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
183 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 7, 2017
Primary completion
Mar 5, 2018
Completion
Mar 5, 2018
Last update posted
Nov 2, 2025

2017 – 2018

United States locations

U.S. sites
24
U.S. states
18
U.S. cities
24
Facility City State ZIP Site status
Noesis Pharma, LLC Phoenix Arizona 85032
Excell Research, Inc Oceanside California 92056
Collaborative Neuroscience Network, LLC. Torrance California 90502
PAB Clinical Research Brandon Florida 33511
Avail Clinical Research, LLC DeLand Florida 32720
Clinical Neuroscience Solutions, Inc Orlando Florida 32801
Chicago Research Center, Inc Chicago Illinois 60634
Medisphere Medical Research Center, LLC Evansville Indiana 47714
Infinity Medical Research, Inc North Dartmouth Massachusetts 02747
Elite Clinical Research, LLC Jackson Mississippi 39202
The Center For Pharmaceutical Research Kansas City Missouri 64114
Advanced Biomedical Research of America Las Vegas Nevada 89123
NY Scientific Brooklyn New York 11235
Neurobehavioral Research, Inc Cedarhurst New York 11516
Private Practice Raleigh North Carolina 27609
PMG of Winston-Salem, LLC Winston-Salem North Carolina 27103
Neuro-Behavioral Clinical Research, Inc Canton Ohio 44718
University of Cincinnati Cincinnati Ohio 45219
Summit Research Network Portland Oregon 97210
Lehigh Center for Clinical Research Allentown Pennsylvania 18104
Omega Medical Research Warwick Rhode Island 02886
Meridian Clinical Research Dakota Dunes South Dakota 57049
ClinSearch, LLC Chattanooga Tennessee 37421
Clinical Investigation Specialists, Inc Kenosha Wisconsin 53142

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03092726, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 2, 2025 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03092726 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →